CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
CORXEL expands its cardiometabolic pipeline into obesity and diabetes DECEMBER 23, 2024 —...
Read MoreCORXEL expands its cardiometabolic pipeline into obesity and diabetes DECEMBER 23, 2024 —...
Read MoreDecember 26, 2024 – Alexandra Ibanez, a mother whose life was transformed after a complex surgery...
Read MoreDECEMBER 24 2024- Representing the top 7% of physicians in the U.S., physician directory...
Read MoreDecember 23, 2024 – As 2024 comes to a close, Broward Health is looking back at the Top 10...
Read MoreDecember 24, 2024 — This holiday season, Lee Health is giving the community the gift of...
Read More